Clinical Research Organization Archives - Healthentia https://healthentia.com/tag/clinical-research-organization/ Tue, 05 Aug 2025 10:50:40 +0000 en-US hourly 1 https://healthentia.com/wp-content/uploads/2020/04/cropped-favicon_512-32x32.png Clinical Research Organization Archives - Healthentia https://healthentia.com/tag/clinical-research-organization/ 32 32 193384636 AI state-of-play around clinical research https://healthentia.com/ai-state-of-play-around-clinical-research/ Fri, 10 Nov 2023 12:28:01 +0000 https://healthentia.com/?p=20150 CATEGORY: eHealth, Health monitoring, telemonitoring, COPD Remote patient monitoring SOURCE: Int. J. Environ. Res. Public Health 2020, 17(21), 7893; https://doi.org/10.3390/ijerph17217893 Acceptance and Potential Impact of the eWALL Platform for Health Monitoring and Promotion in Persons with a Chronic Disease or Age-Related Impairment Francesco Infarinato, Stephanie Jansen-Kosterink, Paola Romano, Lex van Velsen, Harm op den Akker, Federica Rizza, Marco Ottaviani, Sofoklis Kyriazakos, Beatrix Wais-Zechmann, Markus Garschall, Stefano Bonassi,...

The post AI state-of-play around clinical research appeared first on Healthentia.

]]>

CATEGORY: eHealth, Health monitoring, telemonitoring, COPD Remote patient monitoring

SOURCE: Int. J. Environ. Res. Public Health 2020, 17(21), 7893; https://doi.org/10.3390/ijerph17217893

Acceptance and Potential Impact of the eWALL Platform for Health Monitoring and Promotion in Persons with a Chronic Disease or Age-Related Impairment

Francesco Infarinato, Stephanie Jansen-Kosterink, Paola Romano, Lex van Velsen, Harm op den Akker, Federica Rizza, Marco Ottaviani, Sofoklis Kyriazakos, Beatrix Wais-Zechmann, Markus Garschall, Stefano Bonassi, and Hermie J. Hermens

Abstract

Pervasive health technologies can increase the effectiveness of personal health monitoring and training, but more user studies are necessary to understand the interest for these technologies, and how they should be designed and implemented. In the present study, we evaluated eWALL, a user-centered pervasive health technology consisting of a platform that monitors users' physical and cognitive behavior, providing feedback and motivation via an easy-to-use, touch-based user interface. The eWALL was placed for one month in the home of 48 subjects with a chronic condition (chronic obstructive pulmonary disease-COPD or mild cognitive impairment-MCI) or with an age-related impairment. User acceptance, platform use, and potential clinical effects were evaluated using surveys, data logs, and clinical scales. Although some features of the platform need to be improved before reaching technical maturity and making a difference in patients' lives, the real-life evaluation of eWALL has shown how some features may influence patients' intention to use this promising technology. Furthermore, this study made it clear how the free use of different health apps is modulated by the real needs of the patient and by their usefulness in the context of the patient's clinical status.

The post AI state-of-play around clinical research appeared first on Healthentia.

]]>
20150
HAEMOPHILIA https://healthentia.com/haemophilia-power-study/ Thu, 09 Dec 2021 16:01:27 +0000 https://healthentia.com/?p=18943 Study Details Type: Non-interventional Disease: Haemophilia A Sites: 20 sites in Italy Start: January 2020 Population: 150 patients Duration: 12 months Study Description POWER is a multicenter non-interventional study to evaluate the physical activity, bleeding incidence, and Health-related Quality of Life in patients with Haemophilia A without inhibitors receiving the standard of care treatment. the...

The post HAEMOPHILIA appeared first on Healthentia.

]]>

HAEMOPHILIA - Power Study

Study Details

  • Type: Non-interventional
  • Disease: Haemophilia A
  • Sites: 20 sites in Italy
  • Start: January 2020
  • Population: 150 patients
  • Duration: 12 months

Study Description

POWER is a multicenter non-interventional study to evaluate the physical activity, bleeding incidence, and Health-related Quality of Life in patients with Haemophilia A without inhibitors receiving the standard of care treatment. the above outcomes will be collected through a Fitbit tracking device and Healthentia ePRO, customized for the purposes of the Study. This study is in partnership with a Clinical Research Organization (CRO) Cros NT and an eCRF technology provider Arithmos Life Sciences for a Top5 Pharma.

Study Design & Method

Patients will receive a Fitbit device (i.e monitoring bracelet) that will collect at a daily basis Real-World Data like activity (i.e. steps per day), sleep, and vital signs. The device will be delivered during the recruitment, a Fitbit account will be opened and the Application The collected data are then transferred to the patient’s paired device through the Healthentia application downloaded on their smartphone.

During the whole observation period, patients will report through dedicated questionnaires sent to the Power App their wellbeing status in scheduled timings or ad hoc reporting of bleeding or adverse events. A quarterly EQ 5D5L questionnaire is assessing the quality of life and monthly a VAS scale is assessing pain intensity. Absences from school/work and hospitalizations. Bleeding events, treatment adherence and doses and frequency of concomitant medicines are reported monthly.

9122021(3)

Document physical activity, (active minutes, steps count and MET) by age categories (12-17, 18-30, and 31-50 years) in patients with haemophilia A without inhibitors

Frame 9

Collect information on incidence and severity of adverse events (AEs)

9122021(1)

Profile Haemophiliac patients of different categories active vs. sedentary and severe vs. moderate in terms of dif aspects

09122021(9)

Evaluate the relationship between physical activity (type and intensity) and bleedings

The post HAEMOPHILIA appeared first on Healthentia.

]]>
18943